2B | Tenu Tech Brief

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

• Vivtex’s technology uses AI and high throughput screening to identify the combinations of drug ingredients that can deliver peptides through gastrointestinal tissue • Besides Nov

Wayve raises $1.2B with plans to bring robotaxis to London

• Wayve plans to launch commercial trials of robotaxis using its AI Driver this year • Source: Wayve Wayve Technologies Ltd • today said it has closed a Series D round of $1 • 2 bi